FATE
Fate Therapeutics Inc
2.30$
-4.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Fate Therapeutics Inc (FATE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -38 | -37 | -33 | -32 | -29 | -28 | -34 | -25 | -24 | -23 | -31 | -23 | -102 | |
| 4.7 | 4.9 | 4.8 | 4.7 | 4.6 | 4.8 | 3.3 | 3.3 | 3.2 | 3.1 | 2.1 | 2.8 | 11 | |
| 10 | 9.5 | 11 | 9.6 | 12 | 9.1 | 7.4 | 7.2 | 4.9 | 5.5 | 3.9 | 3.5 | 18 | |
| -2.8 | -0.2 | 0.6 | -3.8 | 3.1 | -1.9 | -5.4 | 0.1 | 0.5 | 1.1 | -6.0 | -0.1 | -4.5 | |
| 0.6 | 0.2 | 0.1 | 0.1 | 0.5 | 0.1 | 1.2 | 1.4 | 2.2 | 1.2 | 0.2 | 0.1 | 3.7 | |
| 25 | 45 | 17 | -53 | 25 | 23 | 43 | 20 | 21 | 28 | 24 | 15 | 87 | |
| – | -0.2 | – | -0.7 | 0.7 | -0.7 | – | – | – | – | – | – | – | |
| 0.0 | -0.2 | 95 | 1.3 | 0.0 | 3.1 | 0.0 | 1.3 | 2.5 | 1.7 | – | 1.7 | – | |
| -13 | 8.5 | 79 | -84 | 1.0 | -1.9 | 8.9 | -3.7 | -0.6 | 6.0 | -7.2 | -7.1 | -9.0 | |
| -39 | -37 | -33 | -32 | -30 | -28 | -35 | -26 | -27 | -25 | -31 | -24 | -106 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.